SK bioscience Co.,Ltd. (KRX:302440)
South Korea · Delayed Price · Currency is KRW 34,200
+350 (1.03%)
Aug 3, 2026, 3:30 PM KST
SK bioscience Financials Overview
Financials in millions KRW. Fiscal year is January - December.
Millions KRW. Fiscal year is Jan - Dec.
| Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
| Period Ending | Mar '26 Mar 31, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
Revenue Revenue Growth | 665,421 | 651,368 | 267,545 | 369,506 | 456,726 | 929,001 |
Revenue Growth | 66.42% | 143.46% | -27.59% | -19.10% | -50.84% | - |
Gross Profit Gross Profit Growth | 63,795 | 75,177 | 30,079 | 141,824 | 239,283 | 570,033 |
Operating Income Operating Income Growth | -152,911 | -123,502 | -138,431 | -11,988 | 115,014 | 474,220 |
Net Income Net Income Growth | -83,286 | -57,424 | -53,881 | 22,318 | 122,452 | 355,139 |
Earnings Per Share EPS Growth | -1062.89 | -733.00 | -698.00 | 290.00 | 1590.00 | 4810.00 |
EPS Growth | - | - | - | -81.76% | -66.94% | - |
| Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
| Period Ending | Mar '26 Mar 31, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
America America Growth | 84,207 | 98,372 | 24,799 | 185,961 | 217,834 | 48,408 |
Europe Europe Growth | 423,021 | 401,375 | 107,124 | 21,202 | 13,778 | 184,500 |
Asia Asia Growth | 10,934 | 10,232 | 3,551 | 3,893 | 651.33 | 233.27 |
South Korea South Korea Growth | 145,990 | 140,120 | 131,495 | 158,217 | 224,157 | 695,859 |
Middle East Middle East Growth | - | 1,269 | 576.98 | 231.61 | 305.04 | - |
Total Total Growth | 665,421 | 651,368 | 267,545 | 369,506 | 456,726 | 929,001 |
| Fiscal Year | Current | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
| Period Ending | Mar '26 Mar 31, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
Cash & Investments Cash & Investments Growth | 890,157 | 906,301 | 1,158,108 | 1,274,141 | 1,480,806 | 1,645,663 |
Total Debt Total Debt Growth | 538,000 | 469,988 | 392,814 | 20,574 | 113,336 | 106,236 |
Net Cash (Debt) Net Cash Growth | 352,157 | 436,313 | 765,294 | 1,253,568 | 1,367,469 | 1,539,428 |
Net Cash Growth | -54.87% | -42.99% | -38.95% | -8.33% | -11.17% | - |
Net Cash Per Share Net Cash Per Share Growth | 4492.47 | 5567.64 | 9912.96 | 16277.20 | 17754.39 | 20850.38 |
| Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
| Period Ending | Mar '26 Mar 31, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
Operating Cash Flow Operating Cash Flow Growth | -2,770 | 102,507 | -128,020 | 29,346 | -124,958 | 536,594 |
Capital Expenditures CapEx Growth | -177,077 | -183,091 | -164,413 | -43,461 | -72,993 | -42,907 |
Free Cash Flow Free Cash Flow Growth | -179,846 | -80,584 | -292,433 | -14,114 | -197,951 | 493,686 |
Free Cash Flow Growth | - | - | - | - | - | - |
| Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
| Period Ending | Mar '26 Mar 31, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
Gross Margin | 9.59% | 11.54% | 11.24% | 38.38% | 52.39% | 61.36% |
Operating Margin | -22.98% | -18.96% | -51.74% | -3.24% | 25.18% | 51.05% |
Pretax Margin | -18.02% | -13.18% | -33.31% | 1.98% | 31.03% | 50.71% |
Profit Margin | -12.52% | -8.82% | -20.14% | 6.04% | 26.81% | 38.23% |
FCF Margin | -27.03% | -12.37% | -109.30% | -3.82% | -43.34% | 53.14% |
| Fiscal Year | Current | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
| Period Ending | Aug '26 Aug 3, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
PE Ratio | - | - | - | 247.72 | 46.09 | 48.47 |
Forward PE | - | 173.78 | 173.78 | 173.78 | 24.69 | 23.37 |
P/FCF Ratio | - | - | - | - | - | 34.87 |
PS Ratio | 4.03 | 5.80 | 14.76 | 14.96 | 12.36 | 18.53 |